The latest thoracic oncology news
Cell therapy–checkpoint inhibitor combo shows promise in non-small cell lung cancer
Immunotherapy has become an important tool in the treatment of lung cancer, especially checkpoint inhibitors that…
Browsing: Lung Cancer
TOGA Annual Scientific Meeting 2021 Report
The Thoracic Oncology Group of Australasia (TOGA) was established in 2020 as the lead independent…
Novel therapy shows promise for lung cancer patients with rare EGFR mutation
Lung cancer is the leading cause of cancer death among men and women in the…
Impact of KRAS isoforms in human cancers
KRAS was one of the first oncogenes to be identified, a few decades ago. It…
Quitting smoking after lung cancer diagnosis may extend life without cancer recurrence
A prospective cohort study found that quitting smoking after being diagnosed with early-stage non-small cell…
Study identifies MET amplification as driver for some non-small cell lung cancers
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the…
Preventing lung cancer’s unwelcome return
When a doctor gives a patient antibiotics for a bacterial infection, they usually require them…
Lung cancer screening: the cost of inaction
A report published today, ‘Lung Cancer Screening: The Cost of Inaction’, shows that lung cancer…
Potential marker for success of immunotherapy in the treatment of lung cancer
Lung cancer has the highest mortality rate of all cancers, and treatment options are extremely…
Primary lung cancers detected by LDCT are at lower risk of brain metastases
Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced risk…